Icon (ICLR) Cash from Financing Activities (2009 - 2026)
Icon (ICLR) posted quarterly Cash from Financing Activities of -$8.1 million for Q2 2026, up 96.83% year-over-year from -$4.1 million in Q2 2025, and down 27.65% quarter-over-quarter from -$6.4 million in Q1 2026.
Icon (ICLR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Cash from Financing Activities for 18 consecutive years, with -$8.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Financing Activities rose 96.83% year-over-year to -$8.1 million; the TTM figure through Jun 2026 stood at -$277.0 million (up 72.58% YoY), while the FY2025 annual figure was -$771.3 million, up 7.87% from the prior year.
- Cash from Financing Activities slipped to -$8.1 million in Q2 2026 per ICLR's latest filing, from -$6.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at -$5.8 million in Q4 2025 and bottomed at -$404.0 million in Q4 2024.
- Historically, Cash from Financing Activities has averaged -$185.1 million across 5 years, with a median of -$189.7 million in 2022.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 53792.44% — and 2025, when it surged 98.57%.
- Icon's Cash from Financing Activities stood at -$193.1 million in 2022, then sank by 32.31% to -$255.5 million in 2023, then tumbled by 58.08% to -$404.0 million in 2024, then soared by 98.57% to -$5.8 million in 2025, then tumbled by 40.15% to -$8.1 million in 2026.
- Business Quant data shows ICLR's Cash from Financing Activities at -$8.1 million in Q2 2026, -$6.4 million in Q1 2026, and -$5.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Icon | 12.52 Bn | 12.52 Bn | 479.29 Mn | -8.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.12 Mn |
| Jun 30, 2026 | -8.12 Mn |
| Mar 31, 2026 | -6.36 Mn |
| Mar 31, 2026 | -6.36 Mn |
| Dec 31, 2025 | -5.79 Mn |
| Dec 31, 2025 | -5.79 Mn |
| Sep 30, 2025 | -256.77 Mn |
| Sep 30, 2025 | -256.77 Mn |
| Jun 30, 2025 | -255.86 Mn |
| Jun 30, 2025 | -255.86 Mn |
| Mar 31, 2025 | -252.83 Mn |
| Mar 31, 2025 | -252.83 Mn |
| Dec 31, 2024 | -403.96 Mn |
| Dec 31, 2024 | -403.96 Mn |
| Sep 30, 2024 | -97.78 Mn |
| Sep 30, 2024 | -97.78 Mn |
| Jun 30, 2024 | -71.75 Mn |
| Jun 30, 2024 | -71.75 Mn |
| Mar 31, 2024 | -263.70 Mn |
| Mar 31, 2024 | -263.70 Mn |